159 related articles for article (PubMed ID: 17961878)
1. Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.
Hubby B; Talarico T; Maughan M; Reap EA; Berglund P; Kamrud KI; Copp L; Lewis W; Cecil C; Norberg P; Wagner J; Watson A; Negri S; Burnett BK; Graham A; Smith JF; Chulay JD
Vaccine; 2007 Nov; 25(48):8180-9. PubMed ID: 17961878
[TBL] [Abstract][Full Text] [Related]
2. Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus.
Reap EA; Morris J; Dryga SA; Maughan M; Talarico T; Esch RE; Negri S; Burnett B; Graham A; Olmsted RA; Chulay JD
Vaccine; 2007 Oct; 25(42):7441-9. PubMed ID: 17870214
[TBL] [Abstract][Full Text] [Related]
3. Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept.
Erdman MM; Kamrud KI; Harris DL; Smith J
Vaccine; 2010 Jan; 28(3):594-6. PubMed ID: 19853679
[TBL] [Abstract][Full Text] [Related]
4. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
5. The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.
Thompson JM; Whitmore AC; Staats HF; Johnston R
Vaccine; 2008 Sep; 26(39):4998-5003. PubMed ID: 18656518
[TBL] [Abstract][Full Text] [Related]
6. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
7. Replicon particle vaccine protects swine against influenza.
Bosworth B; Erdman MM; Stine DL; Harris I; Irwin C; Jens M; Loynachan A; Kamrud K; Harris DL
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e99-e103. PubMed ID: 21094422
[TBL] [Abstract][Full Text] [Related]
8. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
[TBL] [Abstract][Full Text] [Related]
9. Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques.
Carroll TD; Matzinger SR; Barro M; Fritts L; McChesney MB; Miller CJ; Johnston RE
Vaccine; 2011 Jan; 29(5):931-40. PubMed ID: 21111777
[TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.
Vander Veen RL; Loynachan AT; Mogler MA; Russell BJ; Harris DL; Kamrud KI
Vaccine; 2012 Mar; 30(11):1944-50. PubMed ID: 22269873
[TBL] [Abstract][Full Text] [Related]
11. Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1).
Yang SG; Wo JE; Li MW; Mi FF; Yu CB; Lv GL; Cao HC; Lu HF; Wang BH; Zhu H; Li LJ
Vaccine; 2009 Dec; 27(52):7451-8. PubMed ID: 19450640
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
15. Lack of interference with immunogenicity of a chimeric alphavirus replicon particle-based influenza vaccine by preexisting antivector immunity.
Uematsu Y; Vajdy M; Lian Y; Perri S; Greer CE; Legg HS; Galli G; Saletti G; Otten GR; Rappuoli R; Barnett SW; Polo JM
Clin Vaccine Immunol; 2012 Jul; 19(7):991-8. PubMed ID: 22623651
[TBL] [Abstract][Full Text] [Related]
16. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
[TBL] [Abstract][Full Text] [Related]
17. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
[TBL] [Abstract][Full Text] [Related]
18. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
19. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
20. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
Wang S; Taaffe J; Parker C; Solórzano A; Cao H; García-Sastre A; Lu S
J Virol; 2006 Dec; 80(23):11628-37. PubMed ID: 16987975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
